EU Rejects Anavex’s Alzheimer’s Drug, But Backs Seven Others

 
• By Eliza Slawther
  
The EMA issued one negative opinion and seven positive opinions for the approval of new drugs in the EU this month (Shutterstock)

More from EU CHMP

More from Europe